miR-30e targets IGF2-regulated osteogenesis in bone marrow-derived mesenchymal stem cells, aortic smooth muscle cells, and ApoE-/- mice

Cardiovascular Research

Volumn 106, Issue 1, 2015, Pages 131-142

  Ding, Wen ^a   Li, Jihe ^a   Singh, Jayanti ^a   Alif, Razan ^b   Vazquez Padron, Roberto I ^a   Gomes, Samirah A ^a   Hare, Joshua M ^a   Shehadeh, Lina A ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MIAMI   (United States)

Author keywords

Calcification; Mesenchymal stem cells; MicroRNA 30e; Osteogenesis; Smooth muscle cells

Indexed keywords

APOLIPOPROTEIN E; CALCIUM; MICRORNA; MICRORNA 30E; OLIGONUCLEOTIDE; OSTEOPONTIN; RECOMBINANT PROTEIN; RECOMBINANT PROTEIN IGF2; SOMATOMEDIN B; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG; IGF2 PROTEIN, MOUSE; MIRN30D MICRORNA, MOUSE;

3' UNTRANSLATED REGION; AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; AORTA VALVE; ARTERY CALCIFICATION; ARTICLE; ATHEROSCLEROSIS; BINDING SITE; BONE DEVELOPMENT; BONE MARROW DERIVED MESENCHYMAL STEM CELL; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE OVEREXPRESSION; GENE REPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LIVER; LUCIFERASE ASSAY; MALE; MICROARRAY ANALYSIS; MOLECULAR BIOLOGY; MOUSE; MUTAGENESIS; NONHUMAN; OSTEOBLAST; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; SMOOTH MUSCLE FIBER; ANIMAL; BONE MARROW CELL; C57BL MOUSE; CALCINOSIS; CELL CULTURE; COMPARATIVE STUDY; CYTOLOGY; DEFICIENCY; DISEASE MODEL; DOWN REGULATION; GENETICS; KNOCKOUT MOUSE; MESENCHYMAL STROMA CELL; PATHOPHYSIOLOGY; PHYSIOLOGY; VASCULAR SMOOTH MUSCLE;

AGING; ANIMALS; AORTA; APOLIPOPROTEINS E; BONE MARROW CELLS; CALCINOSIS; CELL DIFFERENTIATION; CELLS, CULTURED; DISEASE MODELS, ANIMAL; DOWN-REGULATION; INSULIN-LIKE GROWTH FACTOR II; MALE; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICRORNAS; MUSCLE, SMOOTH, VASCULAR; OSTEOGENESIS;

EID: 84926679819     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvv030     Document Type: Article

References (34)

1. Johnson RC, Leopold JA, Loscalzo J. Vascular calcification: pathobiological mechanisms and clinical implications. Circ Res 2006;99:1044-1059
2. Cho HJ, Lee HJ, Song MK, Seo JY, Bae YH, Kim JY, Lee HY, Lee W, Koo BK, Oh BH, Park YB, Kim HS. Vascular calcifying progenitor cells possess bidirectional differentiation potentials. PLoS Biol 2013;11:e1001534
3. Naik V, Leaf EM, Hu JH, Yang HY, Nguyen NB, Giachelli CM, Speer MY. Sources of cells that contribute to atherosclerotic intimal calcification: an in vivo genetic fate mapping study. Cardiovasc Res 2012;94:545-554
4. Eguchi T, Watanabe K, Hara ES, Ono M, Kuboki T, Calderwood SK. Ostemir: a novel panel of microrna biomarkers in osteoblastic and osteocytic differentiation from mesencymal stem cells. PLoS ONE 2013;8:e58796
5. Huang J, Zhao L, Xing L, Chen D. Microrna-204 regulates runx2 protein expression and mesenchymal progenitor cell differentiation. Stem Cells 2010;28:357-364
6. Eskildsen T, Taipaleenmaki H, Stenvang J, Abdallah BM, Ditzel N, Nossent AY, Bak M, Kauppinen S, Kassem M. Microrna-138 regulates osteogenic differentiation of human stromal (mesenchymal) stem cells in vivo. Proc Natl Acad Sci USA 2011;108: 6139-6144
7. Wu T, Zhou H, Hong Y, Li J, Jiang X, Huang H. Mir-30 family members negatively regulate osteoblast differentiation. J Biol Chem 2012;287:7503-7511
8. Wang J, Guan X, Guo F, Zhou J, Chang A, Sun B, Cai Y, Ma Z, Dai C, Li X, Wang B. Mir-30e reciprocally regulates the differentiation of adipocytes and osteoblasts by directly targeting low-density lipoprotein receptor-related protein 6. Cell Death Dis 2013;4:e845
9. Han H, Wang YH, Qu GJ, Sun TT, Li FQ, Jiang W, Luo SS. Differentiated mirna expression and validation of signaling pathways in apoe gene knockout mice by cross-verification microarray platform. Exp Mol Med 2013;45:e13
10. Gomes SA, Rangel EB, Premer C, Dulce RA, Cao Y, Florea V, Balkan W, Rodrigues CO, Schally AV, Hare JM. S-nitrosoglutathione reductase (gsnor) enhances vasculogenesis by mesenchymal stem cells. Proc Natl Acad Sci USA 2013;110:2834-2839
11. Pierce AL, Dickey JT, Felli L, Swanson P, Dickhoff WW. Metabolic hormones regulate basal and growth hormone-dependent igf2 mrna level in primary cultured coho salmon hepatocytes: effects of insulin, glucagon, dexamethasone, and triiodothyronine. J Endocrinol 2010;204:331-339
12. Park CY, Jeker LT, Carver-Moore K, Oh A, Liu HJ, Cameron R, Richards H, Li Z, Adler D, Yoshinaga Y, Martinez M, Nefadov M, Abbas AK, Weiss A, Lanier LL, de Jong PJ, Bluestone JA, Srivastava D, McManus MT. A resource for the conditional ablation of micrornas in the mouse. Cell Rep 2012;1:385-391
13. O'Brien KD, Kuusisto J, Reichenbach DD, Ferguson M, Giachelli C, Alpers CE, Otto CM. Osteopontin is expressed in human aortic valvular lesions. Circulation 1995;92: 2163-2168
14. Kwon HM, Hong BK, Kang TS, Kwon K, Kim HK, Jang Y, Choi D, Park HY, Kang SM, Cho SY, Kim HS. Expression of osteopontin in calcified coronary atherosclerotic plaques. J Korean Med Sci 2000;15:485-493
15. Majumdar R, Miller DV, Ballman KV, Unnikrishnan G, McKellar SH, Sarkar G, Sreekumar R, Bolander ME, Sundt TM 3rd. Elevated expressions of osteopontin and tenascin c in ascending aortic aneurysms are associated with trileaflet aortic valves as compared with bicuspid aortic valves. Cardiovasc Pathol 2007;16:144-150
16. Watson KE, Bostrom K, Ravindranath R, Lam T, Norton B, Demer LL. Tgf-beta 1 and 25-hydroxycholesterol stimulate osteoblast-like vascular cells to calcify. J Clin Invest 1994;93:2106-2113
17. Sugihara H, Ishimoto T, Watanabe M, Sawayama H, Iwatsuki M, Baba Y, Komohara Y, Takeya M, Baba H. Identification of mir-30e. ∗ regulation of bmi1 expression mediated by tumor-associated macrophages in gastrointestinal cancer. PLoS ONE 2013;8:e81839
18. Bilousova G, Jun du H, King KB, De Langhe S, Chick WS, Torchia EC, Chow KS, Klemm DJ, Roop DR, Majka SM. Osteoblasts derived from induced pluripotent stem cells form calcified structures in scaffolds both in vitro and in vivo. Stem Cells 2011;29: 206-216
19. Rajamannan NM, Subramaniam M, Rickard D, Stock SR, Donovan J, Springett M, Orszulak T, Fullerton DA, Tajik AJ, Bonow RO, Spelsberg T. Human aortic valve calcification is associated with an osteoblast phenotype. Circulation 2003;107:2181-2184
20. Zhu D, Mackenzie NC, Millan JL, Farquharson C, Macrae VE. Upregulation of igf2 expression during vascular calcification. J Mol Endocrinol 2014;52:77-85
21. Hardouin SN, Guo R, Romeo PH, Nagy A, Aubin JE. Impaired mesenchymal stem cell differentiation and osteoclastogenesis in mice deficient for igf2-p2 transcripts. Development 2011;138:203-213
22. Lee KS, Kim HJ, Li QL, Chi XZ, Ueta C, Komori T, Wozney JM, Kim EG, Choi JY, Ryoo HM, Bae SC. Runx2 is a common target of transforming growth factor beta1 and bone morphogenetic protein 2, and cooperation between runx2 and smad5 induces osteoblast-specific gene expression in the pluripotent mesenchymal precursor cell line c2c12. Mol Cell Biol 2000;20:8783-8792
23. Ge Y, Sun Y, Chen J. Igf-ii is regulated by microrna-125b in skeletal myogenesis. J Cell Biol 2011;192:69-81
24. Zhang Y, Xie RL, Croce CM, Stein JL, Lian JB, van Wijnen AJ, Stein GS. A program of micrornas controls osteogenic lineage progression by targeting transcription factor runx2. Proc Natl Acad Sci USA 2011;108:9863-9868
25. Brennecke J, Stark A, Russell RB, Cohen SM. Principles of microrna-target recognition. PLoS Biol 2005;3:e85
26. Sinnaeve PR, Donahue MP, Grass P, Seo D, Vonderscher J, Chibout SD, Kraus WE, Sketch M Jr, Nelson C, Ginsburg GS, Goldschmidt-Clermont PJ, Granger CB. Gene expression patterns in peripheral blood correlate with the extent of coronary artery disease. PLoS ONE 2009;4:e7037
27. Liao M, Zou S, Weng J, Hou L, Yang L, Zhao Z, Bao J, Jing Z. A microrna profile comparison between thoracic aortic dissection and normal thoracic aorta indicates the potential role of micrornas in contributing to thoracic aortic dissection pathogenesis. J Vasc Surg 2011;53:1341-1349 e1343
28. Khanna A, Muthusamy S, Liang R, Sarojini H, Wang E. Gain of survival signaling by downregulation of three key mirnas in brain of calorie-restricted mice. Aging (Albany NY) 2011; 3:223-236
29. Zaina S, Pettersson L, Ahren B, Branen L, Hassan AB, Lindholm M, Mattsson R, Thyberg J, Nilsson J. Insulin-like growth factor ii plays a central role in atherosclerosis in a mouse model. J Biol Chem. 2002;277:4505-4511
30. Chen L, Jiang W, Huang J, He BC, Zuo GW, Zhang W, Luo Q, Shi Q, Zhang BQ, Wagner ER, Luo J, Tang M, Wietholt C, Luo X, Bi Y, Su Y, Liu B, Kim SH, He CJ, Hu Y, Shen J, Rastegar F, Huang E, Gao Y, Gao JL, Zhou JZ, Reid RR, Luu HH, Haydon RC, He TC, Deng ZL. Insulin-like growth factor 2 (igf-2) potentiates bmp-9-induced osteogenic differentiation and bone formation. J Bone Miner Res 2010;25:2447-2459
31. Hamidouche Z, Fromigue O, Ringe J, Haupl T, Marie PJ. Crosstalks between integrin alpha 5 and igf2/igfbp2 signalling trigger human bone marrow-derived mesenchymal stromal osteogenic differentiation. BMC Cell Biol 2010;11:44
32. Kang H, Sung J, Jung HM, Woo KM, Hong SD, Roh S. Insulin-like growth factor 2 promotes osteogenic cell differentiation in the parthenogenetic murine embryonic stem cells. Tissue Eng Part A 2012;18:331-341
33. Palermo C, Manduca P, Gazzerro E, Foppiani L, Segat D, Barreca A. Potentiating role of igfbp-2 on igf-ii-stimulated alkaline phosphatase activity in differentiating osteoblasts.Am J Physiol Endocrinol Metab 2004;286:E648-E657
34. Bergman D, Halje M, Nordin M, EngstromW. Insulin-like growth factor 2 in development and disease: a mini-review. Gerontology 2013;59:240-249